Harbor BioSciences to receive patent for Apoptone in treatment of prostate cancer, breast cancer and benign prostatic hypertrophy
November 12, 2015
One of the key investment areas must be the funding of surveillance systems that track, measure the impact and allow for reporting of hypertension cases. As noted in the report, hypertension provides one of the most compelling conditions justifying the creation of a state and local NHANES-like survey providing representative population-based objective clinical information. Accurate information on sodium intake or the content of sodium in specific foods that contribute to sodium intake is necessary for monitoring its reduction. This data is not currently available in a systematic or timely fashion and this hampers efforts to evaluate progress made in reducing sodium intake in the American population.
The National Forum for Heart Disease and Stroke Prevention believes that the burden of hypertension cannot be resolved solely by reliance upon federal or state resources. Private-public partnerships have creatively complemented declining government resources to tackle a myriad health issues and must do so in the case of hypertension. We need not look further than the ground gained when political commitment and resources were made available in the fight against tobacco, breast cancer, or HIV/AIDS, to name a few.
Given the economic burden and health impact associated with hypertension, all stakeholders must wake up, get up, and together take action to make a difference today. The 1 in 3 people living with hypertension and the families and friends of the 1 in 6 people dying of hypertension can wait no longer.
SOURCE National Forum for Heart Disease and Stroke Prevention